Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 866

1.

Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.

Ferrara R, Mezquita L, Texier M, Lahmar J, Audigier-Valette C, Tessonnier L, Mazieres J, Zalcman G, Brosseau S, Le Moulec S, Leroy L, Duchemann B, Lefebvre C, Veillon R, Westeel V, Koscielny S, Champiat S, Ferté C, Planchard D, Remon J, Boucher ME, Gazzah A, Adam J, Bria E, Tortora G, Soria JC, Besse B, Caramella C.

JAMA Oncol. 2018 Sep 6. doi: 10.1001/jamaoncol.2018.3676. [Epub ahead of print]

PMID:
30193240
2.

Endobronchial ultrasound-guided fine-needle aspiration for pulmonary carcinomas genotyping: experience with 398 cases including rapid EGFR/KRAS analysis in 43 cases.

Ghigna MR, Crutu A, Florea V, Feuillet-Soummer S, Baldeyrou P, Adam J, Lacroix L, Besse B, Mercier O, Fadel E, Dorfmuller P, El Ayoubi R, Thomas de Montpréville V.

J Thorac Dis. 2018 Jul;10(7):4653-4658. doi: 10.21037/jtd.2018.06.157.

3.

Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy.

Ou D, Adam J, Garberis I, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y.

Radiother Oncol. 2018 Aug 29. pii: S0167-8140(18)33451-0. doi: 10.1016/j.radonc.2018.08.013. [Epub ahead of print]

PMID:
30172455
4.

Cohort Profile: LIFE course study in CARdiovascular disease Epidemiology (LIFECARE).

Shafiq M, Fong AYY, Tai ES, Nang EEK, Wee HL, Adam J, Woodward M, Sritara P, Poulton R, Sy R, Venkataraman K.

Int J Epidemiol. 2018 Aug 24. doi: 10.1093/ije/dyy168. [Epub ahead of print] No abstract available.

PMID:
30165399
5.

Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT).

Mohkam K, Rayar M, Adam JP, Muscari F, Rode A, Merle P, Pradat P, Bauler S, Delfour I, Chiche L, Ducerf C, Boudjema K, Lesurtel M, Laurent C, Mabrut JY.

BMC Cancer. 2018 Aug 23;18(1):844. doi: 10.1186/s12885-018-4667-0.

6.

Night Shift Work Affects Urine Metabolite Profiles of Nurses with Early Chronotype.

Rotter M, Brandmaier S, Covic M, Burek K, Hertel J, Troll M, Bader E, Adam J, Prehn C, Rathkolb B, Hrabe de Angelis M, Grabe HJ, Daniel H, Kantermann T, Harth V, Illig T, Pallapies D, Behrens T, Brüning T, Adamski J, Lickert H, Rabstein S, Wang-Sattler R.

Metabolites. 2018 Aug 21;8(3). pii: E45. doi: 10.3390/metabo8030045.

7.

Significant dose reduction using synchrotron radiation computed tomography: first clinical case and application to high resolution CT exams.

Labriet H, Nemoz C, Renier M, Berkvens P, Brochard T, Cassagne R, Elleaume H, Estève F, Verry C, Balosso J, Adam JF, Brun E.

Sci Rep. 2018 Aug 21;8(1):12491. doi: 10.1038/s41598-018-30902-y.

8.

Concurrent daily Cisplatin and high dose radiotherapy in patients with stage III non-small cell lung cancer.

Dieleman EMT, Uitterhoeve ALJ, van Hoek MW, van Os RM, Wiersma J, Koolen MGJ, Kolff MW, Koning CCE, Adam JA, Verberne HJ, Annema JT, Rasch CRN.

Int J Radiat Oncol Biol Phys. 2018 Jul 25. pii: S0360-3016(18)31641-9. doi: 10.1016/j.ijrobp.2018.07.188. [Epub ahead of print]

9.

Impact of Weight Reduction During Adolescence on Parameters of Cardiac Geometry and Function in Obese Children.

Erbs S, Broniecki H, Scheuermann K, Winzer E, Adam J, Spielau U, Woitek F, Sandri M, Zimmer M, Besler C, Kiess W, Linke A, Körner A, Mangner N.

JACC Cardiovasc Imaging. 2018 Jul 13. pii: S1936-878X(18)30515-1. doi: 10.1016/j.jcmg.2018.05.023. [Epub ahead of print] No abstract available.

PMID:
30031701
10.

Optimal Multimodal Treatment for Desmoplastic Small Round Cell Tumors.

Mir O, Adam J, Honoré C.

JAMA Oncol. 2018 Sep 1;4(9):1301. doi: 10.1001/jamaoncol.2018.2146. No abstract available.

PMID:
30003230
11.

Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative.

Auguste A, Genestie C, De Bruyn M, Adam J, Le Formal A, Drusch F, Pautier P, Crosbie EJ, MacKay H, Kitchener HC, Powell M, Pollock PM, Mileshkin L, Edmondson RJ, Nout R, Nijman HW, Creutzberg CL, Bosse T, Leary A.

Mod Pathol. 2018 Jun 28. doi: 10.1038/s41379-018-0055-1. [Epub ahead of print]

PMID:
29955143
12.

Gender-dependent association of diabetes mellitus with mortality in patients undergoing transcatheter aortic valve replacement.

Linke A, Schlotter F, Haussig S, Woitek FJ, Stachel G, Adam J, Höllriegel R, Lindner A, Mohr FW, Schuler G, Kiefer P, Leontyev S, Thiele H, Borger MA, Holzhey D, Mangner N.

Clin Res Cardiol. 2018 Jun 25. doi: 10.1007/s00392-018-1309-0. [Epub ahead of print]

PMID:
29943273
13.

PHD2 inactivation in Type I cells drives HIF-2α-dependent multilineage hyperplasia and the formation of paraganglioma-like carotid bodies.

Fielding JW, Hodson EJ, Cheng X, Ferguson DJP, Eckardt L, Adam J, Lip P, Maton-Howarth M, Ratnayaka I, Pugh CW, Buckler KJ, Ratcliffe PJ, Bishop T.

J Physiol. 2018 Jun 19. doi: 10.1113/JP275996. [Epub ahead of print]

PMID:
29917232
14.

Insights into mechanism and functional consequences of heme binding to hemolysin-activating lysine acyltransferase HlyC from Escherichia coli.

Peherstorfer S, Brewitz HH, Paul George AA, Wißbrock A, Adam JM, Schmitt L, Imhof D.

Biochim Biophys Acta. 2018 Sep;1862(9):1964-1972. doi: 10.1016/j.bbagen.2018.06.012. Epub 2018 Jun 15.

PMID:
29908817
15.

Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.

Arnedos M, Bayar MA, Cheaib B, Scott V, Bouakka I, Valent A, Adam J, Leroux-Kozal V, Marty V, Rapinat A, Mazouni C, Sarfati B, Bieche I, Balleyguier C, Gentien D, Delaloge S, Lacroix-Triki M, Michiels S, Andre F.

Ann Oncol. 2018 Aug 1;29(8):1755-1762. doi: 10.1093/annonc/mdy202.

PMID:
29893769
16.

18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.

Adam JA, Arkies H, Hinnen K, Stalpers LJ, van Waesberghe JH, Stoker J, van Os R, Laan JJ, Mom CH, van Eck-Smit BL.

Q J Nucl Med Mol Imaging. 2018 Jun 4. doi: 10.23736/S1824-4785.18.03083-2. [Epub ahead of print]

PMID:
29869485
17.

Long-Term Outcome After Surgery for a Localized Retroperitoneal Soft Tissue Sarcoma in Elderly Patients: Results from a Retrospective, Single-Center Study.

Sourrouille I, Macovei R, Faron M, Le Péchoux C, Mir O, Adam J, Dumont S, Terrier P, Le Cesne A, Honoré C.

Ann Surg Oncol. 2018 Aug;25(8):2201-2208. doi: 10.1245/s10434-018-6529-z. Epub 2018 May 24.

PMID:
29797115
18.

Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica.

Mahjoubi L, Cecchi F, Massard C, Calabro F, Gazzah A, Bahleda R, Jamme P, Gelli M, Goere D, Lacroix L, Adam J, Heukamp L, Trenta P, Hembrough T, Soria JC, Sternberg C, Ducreux M.

Tumori. 2018 Mar 1:300891618763215. doi: 10.1177/0300891618763215. [Epub ahead of print]

PMID:
29714649
19.

Predictors of Mortality and Symptomatic Outcome of Patients With Low-Flow Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.

Mangner N, Stachel G, Woitek F, Haussig S, Schlotter F, Höllriegel R, Adam J, Lindner A, Mohr FW, Schuler G, Kiefer P, Leontyev S, Borger MA, Thiele H, Holzhey D, Linke A.

J Am Heart Assoc. 2018 Apr 13;7(8). pii: e007977. doi: 10.1161/JAHA.117.007977.

20.

Effects of Vaginal Lubricants on In-Vitro Progressive Spermatozoa Motility.

Wilson SL, Adam JK, Krishna SBN.

Afr J Reprod Health. 2017 Sep;21(3):96-101.

PMID:
29624933
21.

Overview of Current Concepts in Gastric Intestinal Metaplasia and Gastric Cancer.

Jencks DS, Adam JD, Borum ML, Koh JM, Stephen S, Doman DB.

Gastroenterol Hepatol (N Y). 2018 Feb;14(2):92-101.

22.

Monte Carlo simulations and experimental results on neutron production in the uranium spallation target QUINTA irradiated with 660 MeV protons.

Khushvaktov JH, Adam J, Baldin AA, Furman WI, Gustov SA, Kish YV, Solnyshkin AA, Stegailov VI, Svoboda J, Tichy P, Tsoupko-Sitnikov VM, Tyutyunnikov SI, Vespalec R, Vrzalova J, Wagner V, Yuldashev BS, Zavorka L, Zeman M.

Appl Radiat Isot. 2018 Jul;137:102-107. doi: 10.1016/j.apradiso.2018.03.003. Epub 2018 Mar 10.

PMID:
29602028
23.

Accounting for disturbance history in models: using remote sensing to constrain carbon and nitrogen pool spin-up.

Hanan EJ, Tague C, Choate J, Liu M, Kolden C, Adam J.

Ecol Appl. 2018 Jul;28(5):1197-1214. doi: 10.1002/eap.1718. Epub 2018 Apr 26.

PMID:
29573305
24.

[PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].

Lantuejoul S, Adam J, Girard N, Duruisseaux M, Mansuet-Lupo A, Cazes A, Rouquette I, Gibault L, Garcia S, Antoine M, Vignaud JM, Galateau-Sallé F, Sagan C, Badoual C, Penault-Llorca F, Damotte D; pour le groupe pathologistes thoraciques de valorisation de l’expertise, de la recherche et de l’innovation (PATTERN). Fondation Synergie Lyon Cancer.

Ann Pathol. 2018 Apr;38(2):110-125. doi: 10.1016/j.annpat.2018.01.007. Epub 2018 Mar 21. French.

PMID:
29571563
25.

Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab.

Acero Brand FZ, Suter N, Adam JP, Faulques B, Maietta A, Soulières D, Blais N.

J Immunother Cancer. 2018 Mar 16;6(1):22. doi: 10.1186/s40425-018-0332-z.

26.

Targeting cell cycle dependencies represent a novel therapeutic approach for selected sarcoma subgroups.

Adam J, Postel-Vinay S.

Ann Oncol. 2018 Apr 1;29(4):798-799. doi: 10.1093/annonc/mdy088. No abstract available.

PMID:
29528461
27.

Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome.

Roy C, Adam JP, Morin F, Lemieux-Blanchard É, Doucet S, Friedmann D, Belisle A, Charpentier D.

Curr Oncol. 2018 Feb;25(1):e103-e105. doi: 10.3747/co.25.3779. Epub 2018 Feb 28.

28.

Procarbazine, lomustine and vincristine toxicity in low-grade gliomas.

Jutras G, Bélanger K, Letarte N, Adam JP, Roberge D, Lemieux B, Lemieux-Blanchard É, Masucci L, Ménard C, Bahary JP, Moumdjian R, Berthelet F, Florescu M.

Curr Oncol. 2018 Feb;25(1):e33-e39. doi: 10.3747/co.25.3680. Epub 2018 Feb 28.

29.

A novel antibody-based approach to detect the functional ERCC1-202 isoform.

Kuo MS, Adam J, Dorvault N, Robin A, Friboulet L, Soria JC, Olaussen KA.

DNA Repair (Amst). 2018 Apr;64:34-44. doi: 10.1016/j.dnarep.2018.02.002. Epub 2018 Feb 11.

PMID:
29482102
30.

Experimental optimisation of the X-ray energy in microbeam radiation therapy.

Livingstone J, Stevenson AW, Häusermann D, Adam JF.

Phys Med. 2018 Jan;45:156-161. doi: 10.1016/j.ejmp.2017.12.017. Epub 2017 Dec 29.

PMID:
29472081
31.

DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade.

Touat M, Sourisseau T, Dorvault N, Chabanon RM, Garrido M, Morel D, Krastev DB, Bigot L, Adam J, Frankum JR, Durand S, Pontoizeau C, Souquère S, Kuo MS, Sauvaigo S, Mardakheh F, Sarasin A, Olaussen KA, Friboulet L, Bouillaud F, Pierron G, Ashworth A, Lombès A, Lord CJ, Soria JC, Postel-Vinay S.

J Clin Invest. 2018 Apr 2;128(4):1671-1687. doi: 10.1172/JCI90277. Epub 2018 Mar 19.

32.

Development and Maintenance of Standardized Cross Setting Patient Assessment Data for Post-Acute Care: Summary Report of Findings from Alpha 1 Pilot Testing.

Maria Orlando E, Barbara J G, Adam J R, Sangeeta A, Amy Soo Jin D, Michael Stephen D, Shira H F, Wenjing H, David J K, Steven M, Francesca P, Tepring P, Victoria S, Regina A S, Cathy D S, Brian D S.

Rand Health Q. 2018 Jan 29;7(2):1. eCollection 2018 Jan.

33.

Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer.

Adam J, Le Stang N, Rouquette I, Cazes A, Badoual C, Pinot-Roussel H, Tixier L, Danel C, Damiola F, Damotte D, Penault-Llorca F, Lantuéjoul S.

Ann Oncol. 2018 Apr 1;29(4):953-958. doi: 10.1093/annonc/mdy014.

PMID:
29351573
34.

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma.

Leduc C, Adam J, Louvet E, Sourisseau T, Dorvault N, Bernard M, Maingot E, Faivre L, Cassin-Kuo MS, Boissier E, Dessoliers MC, Robin A, Casiraghi O, Even C, Temam S, Olaussen KA, Soria JC, Postel-Vinay S.

ESMO Open. 2018 Jan 9;3(1):e000257. doi: 10.1136/esmoopen-2017-000257. eCollection 2018.

35.

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.

Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, Ponce S, Ares LP, Leroy L, Audigier-Valette C, Felip E, Zerón-Medina J, Garrido P, Brosseau S, Zalcman G, Mazieres J, Caramela C, Lahmar J, Adam J, Chaput N, Soria JC, Besse B.

JAMA Oncol. 2018 Mar 1;4(3):351-357. doi: 10.1001/jamaoncol.2017.4771.

PMID:
29327044
36.

Purine nucleotide metabolism regulates expression of the human immune ligand MICA.

McCarthy MT, Moncayo G, Hiron TK, Jakobsen NA, Valli A, Soga T, Adam J, O'Callaghan CA.

J Biol Chem. 2018 Mar 16;293(11):3913-3924. doi: 10.1074/jbc.M117.809459. Epub 2017 Dec 26.

PMID:
29279329
37.

A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study.

Guérin C, Beuret P, Constantin JM, Bellani G, Garcia-Olivares P, Roca O, Meertens JH, Maia PA, Becher T, Peterson J, Larsson A, Gurjar M, Hajjej Z, Kovari F, Assiri AH, Mainas E, Hasan MS, Morocho-Tutillo DR, Baboi L, Chrétien JM, François G, Ayzac L, Chen L, Brochard L, Mercat A; investigators of the APRONET Study Group, the REVA Network, the Réseau recherche de la Société Française d’Anesthésie-Réanimation (SFAR-recherche) and the ESICM Trials Group.

Intensive Care Med. 2018 Jan;44(1):22-37. doi: 10.1007/s00134-017-4996-5. Epub 2017 Dec 7.

PMID:
29218379
38.

Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.

Mezquita L, Charrier M, Faivre L, Dupraz L, Lueza B, Remon J, Planchard D, Bluthgen MV, Facchinetti F, Rahal A, Polo V, Gazzah A, Caramella C, Adam J, Pignon JP, Soria JC, Chaput N, Besse B.

Lung Cancer. 2017 Oct;112:10-15. doi: 10.1016/j.lungcan.2017.07.004. Epub 2017 Jul 29.

PMID:
29191581
40.

Liver Transplantation With Old Grafts: A Ten-Year Experience.

Roullet S, Defaye M, Quinart A, Adam JP, Chiche L, Laurent C, Neau-Cransac M.

Transplant Proc. 2017 Nov;49(9):2135-2143. doi: 10.1016/j.transproceed.2017.07.012.

PMID:
29149974
41.

Risk score to predict biliary leakage after elective liver resection.

Mohkam K, Farges O, Vibert E, Soubrane O, Adam R, Pruvot FR, Regimbeau JM, Adham M, Boleslawski E, Mabrut JY; Association de Chirurgie Hépato-Biliaire et de Transplantation (ACHBT) French Hepatectomy Study Group.

Br J Surg. 2018 Jan;105(1):128-139. doi: 10.1002/bjs.10647. Epub 2017 Nov 13.

PMID:
29131313
42.

Evaluation of the Roche® Elecsys and the Diasorin® Liaison S100 kits in the management of mild head injury in the emergency room.

Delefortrie Q, Lejeune F, Kerzmann B, Levy R, Adam JF, Sottiaux T, Grimmelprez A, Vankerkhoven P, Hachimi-Idrissi S.

Clin Biochem. 2018 Feb;52:123-130. doi: 10.1016/j.clinbiochem.2017.11.004. Epub 2017 Nov 7.

PMID:
29122642
43.

Improved survival using specialized multidisciplinary board in sarcoma patients.

Blay JY, Soibinet P, Penel N, Bompas E, Duffaud F, Stoeckle E, Mir O, Adam J, Chevreau C, Bonvalot S, Rios M, Kerbrat P, Cupissol D, Anract P, Gouin F, Kurtz JE, Lebbe C, Isambert N, Bertucci F, Toumonde M, Thyss A, Piperno-Neumann S, Dubray-Longeras P, Meeus P, Ducimetière F, Giraud A, Coindre JM, Ray-Coquard I, Italiano A, Le Cesne A; NETSARC/RREPS and French Sarcoma Group–Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) networks.

Ann Oncol. 2017 Nov 1;28(11):2852-2859. doi: 10.1093/annonc/mdx484.

PMID:
29117335
44.

Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.

Ou D, Garberis I, Adam J, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y.

Radiother Oncol. 2018 Jan;126(1):116-124. doi: 10.1016/j.radonc.2017.10.007. Epub 2017 Nov 1.

PMID:
29079308
45.

[Oxynorm® instant versus Tradonal® odis as level 2 analgesic in an emergency service : a monocentric double blind randomized non-inferiority study].

Van Brussel C, Delefortrie Q, Kerzmann B, Grégoire C, Adam JF.

Rev Med Liege. 2017 Oct;72(10):448-453. French.

PMID:
29058837
46.

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.

Büttner R, Gosney JR, Skov BG, Adam J, Motoi N, Bloom KJ, Dietel M, Longshore JW, López-Ríos F, Penault-Llorca F, Viale G, Wotherspoon AC, Kerr KM, Tsao MS.

J Clin Oncol. 2017 Dec 1;35(34):3867-3876. doi: 10.1200/JCO.2017.74.7642. Epub 2017 Oct 20. Review.

PMID:
29053400
47.

Mountain shadows revisited.

Adam JA.

Appl Opt. 2017 Jul 1;56(19):G26-G35. doi: 10.1364/AO.56.000G26.

PMID:
29047466
48.

PD-1 inhibition in bone sarcoma and soft-tissue sarcoma.

Mir O, Honoré C, Adam J.

Lancet Oncol. 2017 Nov;18(11):1430-1431. doi: 10.1016/S1470-2045(17)30685-X. Epub 2017 Oct 4. No abstract available.

PMID:
28988645
49.

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).

Nordmann S, Vilotitch A, Roux P, Esterle L, Spire B, Marcellin F, Salmon-Ceron D, Dabis F, Chas J, Rey D, Wittkop L, Sogni P, Carrieri P; ANRS CO13 HEPAVIH Study Group.

J Viral Hepat. 2018 Feb;25(2):171-179. doi: 10.1111/jvh.12797. Epub 2017 Nov 20.

PMID:
28984055
50.

Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

Coutzac C, Adam J, Soularue E, Collins M, Racine A, Mussini C, Boselli L, Kamsukom N, Mateus C, Charrier M, Cassard L, Planchard D, Ribrag V, Fizazi K, Loriot Y, Lepage P, Scoazec JY, Robert C, Carbonnel F, Chaput N.

J Crohns Colitis. 2017 Oct 1;11(10):1238-1246. doi: 10.1093/ecco-jcc/jjx081.

PMID:
28967957

Supplemental Content

Loading ...
Support Center